From ImmuneXcite Enlists Body’s First Defender for Immune Attack on Cancer:

Neutrophils and T cells with mAbXcite
Neutrophils and T cells with mAbXcite—

A description of the immune response generated by Lexington, MA-based ImmuneXcite’s “mAbXcite” technology.

Xconomy on Demand

We offer a number of ways to subscribe for free!

Subscribe Now

© 2007-2020, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.